Business.china.org.cn ---- The Definitive Guide to All Your China Business Needs

Statistics

Reports

Laws & Regs

FAQs

Fairs & Expos 2009

RSS

Healthcare & Pharmaceutical

Growing network with dose from IPO

Sinopharm Group Co, China's largest drug distributor, said yesterday it expects to raise as much as HK$8.7 billion (US$1.1 billion) in an initial public offering in Hong Kong to expand its network and import medicines.

-	Growing network with dose from IPO
-	Bayer: accelerating growth in Beijing
-	Merck to boost R&D investment
-	Unilever opens US$72m center
-	Jiangsu Hengrui gets US FDA nod for diabetes drug trials
-	Fosun hikes stake in Tongjitang
-	Pfizer grows R&D work in China
-	Guilin Sanjin's H1 net profit up 13.34%
-	Wyeth Q2 profit up 13% to beat views
-	SSL to open condom factory in Qingdao
-	Pharma firms start work on H1N1 vaccine
-	Guilin Sanjin says IPO price fixed at 19.8 yuan per share
-	Guilin Sanjin sets the China IPO ball rolling
-	China's medicine industry output expected to rise by 20% in 2009
-	Pharma, TCM makers gear up

China Data - June 09

World Expo 2010 Shanghai

China data - February 2009

G20 London Summit

2008 Earnings Release

Guotai Junan's incredible large payroll

The 'seven deadly sins' of Huang Guangyu

Global Financial Crisis

A Century of Wall Street

HK Property Market in May

Bayer: accelerating growth in Beijing

Bayer HealthCare Co Ltd's plant in Beijing was established in 1997 in Beijing Economic Development Area (BDA). Since its opening, the plant has made great progress. Its robust production and sales philosophy has enabled it to gain a lead position in the development of the whole Bayer HealthCare group.

Merck to boost R&D investment

German drug and chemical maker Merck KGaA is stepping up its investment in China and looking at more acquisitions to shore up growth even as it expects to cash in on the nation's medical reform plan, according to senior company officials.

-	Unilever opens US$72m center
-	Jiangsu Hengrui gets US FDA nod for diabetes drug trials
-	Fosun hikes stake in Tongjitang
-	Pfizer grows R&D work in China
-	Guilin Sanjin's H1 net profit up 13.34%
-	Wyeth Q2 profit up 13% to beat views
-	SSL to open condom factory in Qingdao
-	Pharma firms start work on H1N1 vaccine
-	Guilin Sanjin says IPO price fixed at 19.8 yuan per share
-	Guilin Sanjin sets the China IPO ball rolling

-	China's medicine industry output expected to rise by 20% in 2009
-	Pharma, TCM makers gear up
-	Sanofi-aventis invests to expand Beijing plant
-	Pharmaceutical shares lose luster
-	Novartis plans more investment
-	Lilly focuses on R&D as rivals eye M
-	Medicine firms need flexible pricing approach
-	IBM bets big on nation's health reform thrust
-	GSK to invest more in new drug development
-	Vitamin price hike propels Northeast Pharmaceutical

-	Drug firm posts 11% rise in net
-	Zhejiang NHU net sees whopping rise
-	Shanghai medical care value on the rise
-	Pfizer opens new facility in Dalian
-	Novartis China to launch six new drugs this year
-	P&G losing market share to emerging brands
-	Michel Vounatsos appointed new president of MSD China
-	Bayer sets up first R&D center in China
-	China to spend US$124b on healthcare reform
-	Pharma stocks offer new hope

-	China puts 10b yuan on drugs R&D, disease control
-	Government to boost medical services
-	British drug company opens new facility in China
-	Cook Medical to start operation in Shanghai
-	China blacklists 23 websites selling fake drugs
-	New use for biotech pharma plant
-	China shifts reproductive health care spending
-	Health show to be held in Shanghai on Nov. 20
-	Medical products for rural areas
-	Probe into deadly herbal jabs 'ongoing'

-	TCM an important part of China's health system
-	Drug company's production halted for contamination
-	Medical firm doing very well in China
-	Over US$50 mln rural health project launched in China
-	Healthcare reform plan 'too hard to understand'
-	Public feedback sought on reform of healthcare
-	Pharmacy to make new investment
-	Wuxi JV taps into health care growth
-	Foreign firms make a dash for health pie
-	Venturepharm buys Nasdaq-listed drug firm

Bank of China Quotations

July 7-12 China Shenyang Int'l Auto Industry Expo
July 9-12 Qingdao China Int'l Consumer Electronics Show
July 15-18 Shanghai Int'l Machine Tool Fair
July 29-31 Shanghai Int'l Sporting Goods Expo

June 7 Tokyo 2nd China-Japan High-Level Economic Dialogu

June 30 Shanghai 2009 Automotive Engine Technology Seminar

September 8-12 Xiamen China Int'l Fair for Investment and Trade

Government	Investment	Hotels
Guilds	Think-tanks	Automakers
SOEs	Financial	Airlines
Development Zones More Categories >>

-	Output of Major Industrial Products
-	Investment by Various Sectors
-	Foreign Direct Investment by Country or Region
-	National Price Index
-	Value of Major Commodity Import
-	Money Supply
-	Exchange Rate and Foreign Exchange Reserve

-	HK Property Market in February
-	Macao Property Report
-	HK Property Market in January

-	Telecommunications Regulations of the People's Republic of China
-	Anti-monopoly Law of the People's Republic of China
-	Law of the People's Republic of China on Foreign-Capital Enterprises
-	Law of the People's Republic of China on the People's Bank of China
-	Port Law of the People's Republic of China

-	What does the China-Pakistan Free Trade Agreement cover?
-	How to Set up a Foreign Capital Enterprise in China?
-	How Much RMB or Foreign Currency Can Be Physically Carried Out of or Into China?
-	What Is the Electrical Fitting in China?
-	How Does the VAT Works in China?

SiteMap | About Us | RSS | Newsletter | Feedback

THIS SITE